Skip to main content

CORRECTION article

Front. Mol. Biosci., 02 September 2022
Sec. Molecular Diagnostics and Therapeutics

Corrigendum: Comprehensive analysis of the potential immune-related biomarker transporter associated with antigen processing 1 that inhibits metastasis and invasion of ovarian cancer cells

Xiaoxue LiXiaoxue LiShiyu ZengShiyu ZengYiling DingYiling DingYanting NieYanting NieMengyuan Yang
Mengyuan Yang*
  • Department of Obstetrics and Gynecology, The Second Xiangya Hospital of Central South University, Changsha, China

In the published article, there was an error in “Figure 8D” as published. The picture in Figure 8D was wrong when we uploaded the pictures. The corrected Figure 8 and its caption “Downregulation of transporter associated with antigen processing 1 (TAP1) reduces the invasion and migration in ovarian cancer cells” appear below.

FIGURE 8
www.frontiersin.org

FIGURE 8. Downregulation of transporter associated with antigen processing 1 (TAP1) reduces the invasion and migration in ovarian cancer cells. (A) The volcano map of TAP1-related pathways by gene set variation analysis. (B) Enriching pathway analysis in ovarian cancer of TAP1. (C) The migration abilities of OVCAR3 and SKOV3 were photographed (i, ii) and measured (iii) by examining the wound closure after TAP1 knockdown using wound healing assays. Original magnifications, ×100. Scale bars 150 μm. (D) Transwell assays were photographed (i) and measured (ii) to detect the migration abilities after TAP1 knockdown in SKOV3 and OVCAR3 cells. Original magnifications, ×200. Scale bars 100 μm. (E) Colony formation assays were photographed (i) and measured (ii) to detect the proliferation abilities after TAP1 knockdown in SKOV3 and OVCAR3 cells. (F) Effects of TAP1 knockdown on migration-associated protein (E-cadherin and vimentin) and transcription factor (MEF2A and LEF1) were analyzed by western blotting in SKOV3 and OVCAR3 cells (i). Error bars of histogram (ii) represented the SD of triplicate measurements. *p < 0.05; **p < 0.01; ***p < 0.001.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: pan-cancer, ovarian cancer, cervical cancer, transporter associated with antigen processing 1, tumor-infiltrating immune cells, immune checkpoint, metastasis

Citation: Li X, Zeng S, Ding Y, Nie Y and Yang M (2022) Corrigendum: Comprehensive analysis of the potential immune-related biomarker transporter associated with antigen processing 1 that inhibits metastasis and invasion of ovarian cancer cells. Front. Mol. Biosci. 9:984209. doi: 10.3389/fmolb.2022.984209

Received: 01 July 2022; Accepted: 11 August 2022;
Published: 02 September 2022.

Edited by:

William C Cho, QEH, Hong Kong SAR, China

Reviewed by:

Gregory Taylor, Duke University, United States

Copyright © 2022 Li, Zeng, Ding, Nie and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Mengyuan Yang, yangmengyuan_xy@csu.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.